Provided by Tiger Trade Technology Pte. Ltd.

CMS

11.570
-0.290-2.45%
Volume:6.11M
Turnover:70.59M
Market Cap:28.15B
PE:16.11
High:12.130
Open:11.920
Low:11.420
Close:11.860
52wk High:15.449
52wk Low:9.510
Shares:2.43B
HK Float Shares:2.43B
Volume Ratio:0.62
T/O Rate:0.25%
Dividend:0.33
Dividend Rate:2.82%
EPS(LYR):0.718
ROE:8.42%
ROA:5.62%
PB:1.34
PE(LYR):16.11
PS:2.77

Loading ...

China Medical System Says Nmpa Approves Clinical Trials of Cms-d017

Reuters
·
Jul 16

CMS Receives Clinical Trial Approval for Its Novel Complement Factor B Inhibitor in Age-Related Macular Degeneration

Stock News
·
Jul 15

CMS secures NMPA clearance to begin clinical trials of oral complement factor B inhibitor CMS-D017 for age-related macular degeneration

Bulletin Express
·
Jul 15

China Medical System Wins Trial Nod for New AMD Drug CMS-D017

TIPRANKS
·
Jul 15

China Medical System Holdings - Nmpa Approves Clinical Trials of Cms-d017 for Age-related Macular Degeneration

THOMSON REUTERS
·
Jul 15

Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS

Deep News
·
Jul 13

China Medical System to Pay Insilico up to About $177 Million for Central Nervous System Work

Reuters
·
Jul 13

InSilico Medicine, CMS Expand Drug Development Partnership

MT Newswires Live
·
Jul 13

CMS Repurchases 5.38 Million Shares in June, Outstanding Share Count Trimmed to 2.43 Billion

Bulletin Express
·
Jul 02

China Medical System Files Board, Board Committee and Management Disclosure Roster

Reuters
·
Jun 29

CMS Appoints Li Xianliang as Independent Non-Executive Director

Stock News
·
Jun 29

CMS repurchases 0.50 million shares for HK$5.06 million; treasury stock rises to 6.40 million shares

Bulletin Express
·
Jun 24

How NMPA Approval of First-in-Class Rabies Antibody Will Impact China Medical System (SEHK:867) Investors

Simply Wall St.
·
Jun 22

China Medical System Gets China Nod for Rabies Drug Application

MT Newswires
·
Jun 22

CMS Secures Chinese NDA Approval for Novel Anti-Rabies Bispecific Antibody Sileweimimab

Stock News
·
Jun 22

China Medical System says China approves rabies antibody drug Silevimig Injection

Reuters
·
Jun 22

China Medical System - Silevimig Injection Approved by China Nmpa on 22 June 2026

THOMSON REUTERS
·
Jun 22

China Medical System Holdings (SEHK:867) Stock Could Be Below Fair Value After CMS D008 Update

Simply Wall St.
·
Jun 20

CMS Buys Back 400,000 Shares for HKD 4.11 Million, Issued Share Count Trimmed to 2.43 Billion

Bulletin Express
·
Jun 17

CMS Executes Share Buyback, Spending HK$4.11 Million

Stock News
·
Jun 17